121 related articles for article (PubMed ID: 4352254)
1. Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles).
Russell AS; Maini RA; Bailey M; Dumonde DC
Clin Exp Immunol; 1973 Jun; 14(2):181-5. PubMed ID: 4352254
[TBL] [Abstract][Full Text] [Related]
2. Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells.
Cauda R; Grossi CE; Whitley RJ; Tilden AB
J Immunol; 1987 Feb; 138(4):1229-33. PubMed ID: 3027175
[TBL] [Abstract][Full Text] [Related]
3. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
Oxman MN
J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
[TBL] [Abstract][Full Text] [Related]
4. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
[TBL] [Abstract][Full Text] [Related]
5. [Reactivation of herpes zoster infection by varicella-zoster virus].
Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
[TBL] [Abstract][Full Text] [Related]
6. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity to microbial antigens in mother and child.
Russell AS
Clin Exp Immunol; 1975 Dec; 22(3):457-60. PubMed ID: 178473
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunity to varicella-zoster virus as assessed by the migration inhibition test.
Trlifajová J; Svejcar J; Svandová E; Ryba M; Pekárek J
Acta Virol; 1980 Dec; 24(6):406-14. PubMed ID: 6111201
[TBL] [Abstract][Full Text] [Related]
9. Prevention of shingles by varicella zoster virus vaccination.
Holodniy M
Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
[TBL] [Abstract][Full Text] [Related]
10. Preparation of concentrated intracellular precipitating antigens of varicella-zoster and herpes simplex viruses and results obtained with them in the gel precipitation reaction.
Trlifajová J; Sourek J; Ryba M
Acta Virol; 1970 Jan; 14(1):25-34. PubMed ID: 4392074
[No Abstract] [Full Text] [Related]
11. [Immunological response of patients with herpes zoster (author's transl)].
Higa K
Fukuoka Igaku Zasshi; 1982 Mar; 73(3):131-45. PubMed ID: 6286440
[No Abstract] [Full Text] [Related]
12. Antigenic relationship between varicella-herpes zoster and herpes simplex viruses studied by the gel precipitation reaction.
Trlifajová J; Sourek J; Ryba M
Acta Virol; 1971 Jul; 15(4):293-300. PubMed ID: 4398080
[No Abstract] [Full Text] [Related]
13. Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients.
Arvin AM; Pollard RB; Rasmussen LE; Rand KH; Merigan TC
IARC Sci Publ (1971); 1978; (24 Pt 2):745-51. PubMed ID: 221398
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity to varicella-zoster virus demonstrated by lymphocyte transformation in herpes zoster.
Hata S
J Dermatol; 1983 Feb; 10(1):13-6. PubMed ID: 6306084
[No Abstract] [Full Text] [Related]
15. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster vaccine (Zostavax).
Med Lett Drugs Ther; 2006 Sep; 48(1243):73-4. PubMed ID: 16977285
[TBL] [Abstract][Full Text] [Related]
17. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ
J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460
[TBL] [Abstract][Full Text] [Related]
18. Interferon, antibody, and other host factors in herpes zoster.
Stevens DA; Merigan TC
J Clin Invest; 1972 May; 51(5):1170-8. PubMed ID: 5020430
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic characteristics of the pathogenesis of herpes zoster].
Seletskaia TA; Shishov AS; Sysoeva KR
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):180-4. PubMed ID: 3872543
[TBL] [Abstract][Full Text] [Related]
20. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
